Dipole Materials wants to help researchers speed up the development of novel medical devices and improve pharmaceutical drug screening capabilities. Our novel BioPaper technology is a 3D fibrous scaffold that easily fits all of your needs for 3D cell culture and bioprinting. BioPapers offer researchers the opportunity to use scaffolds of biological-derived materials with controlled properties, custom formats, and easy handling for applications in regenerative medicine, challenging the use of synthetic equivalents and transforming traditional cell culture approaches.
Family of BioPaper standards with controlled and reproducible properties. Easily customized for your application!
Advantages of BioPaper
•BioPapers are composed of biologically-derived materials as the preferred 3D substrate compared to synthetically-derived materials
•Easily handled for applications in high-throughput drug screening, in vitro disease models, or 3D bioprinting
•Industry trends demonstrate the 3D cell culture and bioprinting market to grow to $500M by 2020
•Tools for 3D cell culture and bioprinting eliminate substrate preparation time, support reproducibility, and improve standardization of biomaterials
•Completely customizable to fit end-user needs and applications